Abstract
Introduction: COVID-19 related travel restrictions and lockdown status of the country has affected the routine work of most of the health sector. Screening and treatment of retinopathy of prematurity is considered as a procedure which must be continued despite the adverse situation. Methods: ROP register of the Department of Paediatric Ophthalmology was analyzed to see how the pandemic situation affected the ROP screening and treatment. Results: Out of the total number of 363 babies who were screened for ROP 48 developed severe forms of ROP needing treatment. 45 babies could not attend the clinic visits on the given date. Discussion and conclusion: Severe forms of ROP can be treated with one dose of intravitreal injection of bevacizumab. 532nm Green Laser is reserved for zone 3 stage 3 ROP and for babies who develop tractional elements. Robust and prolonged follow up mechanism is necessary to maintain the integrity of the ROP management.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callMore From: Journal of the College of Ophthalmologists of Sri Lanka
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
